Other

Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10

CVS Health Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 increased by 2.6% to $2.83B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 9.6%, from $3.13B to $2.83B.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ1 2019
Last reportedQ3 2025
Metric ID: other_available_for_sale_securities_debt_maturities_afte_afe479

Historical Data

12 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25
Value$4.38B$4.39B$4.40B$4.30B$4.27B$4.11B$3.92B$3.56B$3.13B$2.92B$2.75B$2.83B
QoQ Change—+0.4%+0.3%-2.4%-0.7%-3.8%-4.7%-9.1%-12.2%-6.6%-5.7%+2.6%
YoY Change———-1.8%-2.8%-6.7%-8.9%-16.6%-23.8%-25.4%-22.6%-9.6%
Range$2.75B – $4.40B
CAGR-14.7%
Avg YoY Growth-13.1%
Median YoY Growth-9.6%

Frequently Asked Questions

What is CVS Health's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year 10?
CVS Health (CVS) reported debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year 10 of $2.83B in Q3 2025.
How has CVS Health's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year 10 changed year-over-year?
CVS Health's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year 10 decreased by 9.6% year-over-year, from $3.13B to $2.83B.